Advertisement

Why Is Colfax (CFX) Up 22.4% Since Last Earnings Report?

Information Access and Management (IAM) Platform powers IAM Network - 60,000 + engaged information professionals worldwide.

BEGIN ARTICLE PREVIEW:

It has been about a month since the last earnings report for Colfax (CFX). Shares have added about 22.4% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Colfax due for a pullback? Before we dive into how investors and analysts have reacted as of late, let’s take a quick look at the most recent earnings report in order to get a better handle on the important drivers.Colfax Beats Q1 Earnings Estimates, Withdraws ViewColfax reported better-than-expected results for the first quarter of 2020, with earnings surpassing estimates by 2.7%. Also, the quarter’s sales beat the consensus estimate by 3.1%.The machinery company’s adjusted earnings in the reported quarter were 38 cents per share, surpassing the Zacks Consensus Estimate of 37 cents. Moreover, the bottom line gained 2.7% from the year-ago figure of 37 cents.Revenue DetailsIn the quarter under review, Colfax’s pro forma revenues were $816.4 million, reflecting a year-over-year decline of 4.3%. The result suffered from a 1.4% decline in the existing businesses (due to the pandemic impact on demand) and a 2.9% impact from forex woes.However, the company’s revenues surpassed the Zacks Consensus Estimate of $792.2 million.Further, its sales from …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE

Here’s how technology is helping residents during the COVID-19 pandemic – Scope

here’s how technology is helping residents during the covid-19 pandemic – scope

BEGIN ARTICLE PREVIEW:

Here’s how technology is helping residents during the COVID-19 pandemic

Technology has made it possible for Stanford Medicine residents to continue learning and caring for patients safely during the COVID-19 era.

Author Swati DiDonato, Erna Forgó and Haley ManellaPublished on June 4, 2020June 5, 2020

COVID-19 has changed our identities as resident physicians to the very core. Seemingly overnight, as the virus spread throughout our community, our workplace transformed from one of comforting familiarity to one with uncertainty and fear for the safety of our patients, our coworkers, our families and ourselves.

Rapid innovation and implementation of technology has allowed us to navigate the challenges from this deadly threat and safely care for our patients.

For years, we have walked through the bustling entrance to Stanford Hospital in the early morning, encountering our coworkers, exchanging pleasantries and finishing an extra large cup of coffee before the shift starts.

These weeks have been different. From the moment you approach the front entrance of Stanford Hospital, it is clear that technology has transformed our typical daily workflow. 

Staff line up six feet apart for daily screening. One by one, they snap a photo of a QR code ,which takes them to a screening survey …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “Here’s how technology is helping residents during the COVID-19 pandemic – Scope”

Venture firm is a ‘win-win’ for Koch Industries and company founders: Chase Koch

Information Access and Management (IAM) Platform powers IAM Network - 60,000 + engaged information professionals worldwide.

BEGIN ARTICLE PREVIEW:

The Koch family name often invokes the sprawling Wichita, Kan.-based chemical and energy conglomerate, Koch Industries, which pulls in more than $110 billion in annual revenue and helps fund the family’s philanthropic and political endeavors.But a lesser-known venture firm called Koch Disruptive Technologies — helmed by Chase Koch, the son of multi-billionaire Koch Industries CEO Charles Koch — aims to make waves in the venture space and set a path forward for Koch Industries with notable investments in sectors like tech and healthcare.In a newly released interview, Chase Koch described Koch Disruptive Technologies as a “win-win” for company founders, which receive the resources and expertise made possible by the venture firm’s vicinity to Koch Industries; and for the chemical giant, which can use the firm as laboratory for transforming its holdings.“I spotted an opportunity to say, what if we brought all of Koch Industries together as kind of this Koch laboratory concept and offer that to technology founders in a way that they haven’t experienced,” says Koch, 42, the president of Koch Disruptive Technologies.“But it’s a win-win,” he adds. “That helps Koch Industries as well because we’re on this journey of trying to transform a lot …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “Venture firm is a ‘win-win’ for Koch Industries and company founders: Chase Koch”

Europe Medical Devices Industry Report 2020-2025 – Impact of COVID-19; Postponement of Non-Emergency Elective Surgeries, Medical Device Supply Chain Disruption – ResearchAndMarkets.com

europe medical devices industry report 2020-2025 – impact of covid-19; postponement of non-emergency elective surgeries, medical device supply chain disruption – researchandmarkets.com

BEGIN ARTICLE PREVIEW:

The

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “Europe Medical Devices Industry Report 2020-2025 – Impact of COVID-19; Postponement of Non-Emergency Elective Surgeries, Medical Device Supply Chain Disruption – ResearchAndMarkets.com”

Advanced Manufacturing Facility Driving Innovation in High-Performance Electronics Unveiled by Benchmark and Arizona Government Leaders

advanced manufacturing facility driving innovation in high-performance electronics unveiled by benchmark and arizona government leaders

BEGIN ARTICLE PREVIEW:




TEMPE, Ariz., June 4, 2020 /PRNewswire/ — Benchmark (NYSE: BHE), a global provider of engineering, design, and manufacturing services, today held a virtual grand opening of its new advanced electronics manufacturing facility in Phoenix. Benchmark’s President and CEO Jeff Benck hosted the live webcast and was joined virtually by several dignitaries including Arizona Governor Doug Ducey and Phoenix Mayor Kate Gallego.”As Arizona begins to safely re-energize our economy, Benchmark’s expansion into its new Phoenix facility is positive news,” said Governor Ducey. “We are grateful that companies like Benchmark, which relocated its headquarters from Texas to Arizona, continue to bring hundreds of good-paying jobs to our state.”Benchmark’s new Phoenix facility produces solutions for high-reliability RF, photonics, and high-speed electronic systems in a wide range of market sectors, including: aerospace and defense, computing, complex industrial, medical, and next-generation telecommunications. Benchmark currently serves several high-profile customers within each of these key industries today at the new site.”We’re thrilled to announce the grand opening of our latest Phoenix facility,” said Benck. “Arizona has proven to be an excellent location for Benchmark to grow and thrive. The support we’ve received from the community, government officals, and our state’s great universities have all contributed to …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “Advanced Manufacturing Facility Driving Innovation in High-Performance Electronics Unveiled by Benchmark and Arizona Government Leaders”

Two elite medical journals retract coronavirus papers over data integrity questions

two elite medical journals retract coronavirus papers over data integrity questions

BEGIN ARTICLE PREVIEW:

By Charles PillerJun. 4, 2020 , 5:30 PM

Science’s COVID-19 reporting is supported by the Pulitzer Center.

In the first big research scandal of the COVID-19 era,  The Lancet and The New England Journal of Medicine (NEJM)  today retracted two high-profile papers after a company declined to make the underlying data for both available for an independent audit, following questions being raised about the research. The Lancet paper, which claimed an antimalarial drug touted by President Donald Trump for treatment of COVID-19 could cause serious harm without helping patients, had had a global impact, halting trials of one of the drugs by the World Health Organization (WHO) and others.

Three authors on the Lancet paper requested the retraction, after initiating an independent review of the raw hospital patient data summarized and provided by Surgisphere, a small Chicago-based company operated by Sapan Desai, the fourth author of the study. Desai had previously said he and his co-authors—Harvard University’s Mandeep Mehra, Frank Ruschitzka of the University Hospital Zürich, and Amit Patel, an adjunct faculty member at the University of Utah—were getting such an audit of the data, but the agreement apparently fell apart.

Related

“Our independent peer reviewers informed us that Surgisphere would …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “Two elite medical journals retract coronavirus papers over data integrity questions”

FUJIFILM Sonosite Announces Rich Fabian’s Election To Life Science Washington Executive Committee

fujifilm sonosite announces rich fabian’s election to life science washington executive committee

BEGIN ARTICLE PREVIEW:

BOTHELL, Wash., June 4, 2020 /PRNewswire/ — FUJIFILM Sonosite, Inc., the world leader in point-of-care ultrasound, has announced the election of Rich Fabian, the company’s President and Chief Operating Officer, to the Executive Committee of the Board of Directors of Life Science Washington, a statewide industry association whose mission is to stimulate life science innovation, job creation and ecosystem vibrancy across Washington. Fabian has agreed to serve as Vice Chair of the LSW Board through December 31, 2021.
“We have chosen to put our company headquarters in Washington State because of the lively, world-class scientific and medical community here, which is matched in its enthusiasm by its extraordinary academic institutions and med-tech philanthropies,” said Rich Fabian, President and Chief Operating Officer, FUJIFILM Sonosite, Inc. “I am honored to join the Executive Committee of Life Science Washington, a primary venture ignitor and technology attractor in this area, bringing world experts and innovative solutions into play from across the Pacific and Atlantic to help encourage and accelerate the current revolution in life sciences.”
Sonosite trailblazes the point-of-care ultrasound industry with a progressive leader. In addition to his recent election to the  Life Science Washington Executive Committee, Rich is on the board of the Medical Imaging Technology …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “FUJIFILM Sonosite Announces Rich Fabian’s Election To Life Science Washington Executive Committee”

Assessment of Europe’s Medical Devices Market, 2020-2025

assessment of europe’s medical devices market, 2020-2025

BEGIN ARTICLE PREVIEW:




DUBLIN, June 4, 2020 /PRNewswire/ — The “European Medical Devices Market by Type (Diagnostic Imaging, Endoscopy Equipment, Respiratory Care, Cardiac Monitoring Devices, Haemodialysis Devices, Ophthalmic Devices, Anesthesia Monitoring), End User (Hospitals, Home-care) – Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering.The European medical devices market is projected to reach USD 60.31 billion by 2025 from an estimated USD 47.99 billion in 2020, at a CAGR of 4.7% during the forecast period.This report analyzes the various European Medical Device companies and their adoption patterns in the market. It aims at estimating the market size and future growth potential of the global European Medical Device market for different segments such as devices, end-user, and country. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies.The European Medical Device market is projected to grow at a CAGR of 4.7 % between 2020 and 2025.Factors such as the rising geriatric population, large and established medical technology industry, increasing number of surgical procedures, growing need for cost-containment in the healthcare industry, and the availability of funding for research and product innovation are driving the growth of this market. However, fiscal unsustainability due …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “Assessment of Europe’s Medical Devices Market, 2020-2025”

Titan Medical Announces Development and License Agreements With Medtronic and Senior Secured Loan

titan medical announces development and license agreements with medtronic and senior secured loan

BEGIN ARTICLE PREVIEW:

June 4, 2020

TORONTO–(BUSINESS WIRE)–Titan Medical Inc. (“Titan” or “Titan Medical”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of single-port robotic surgical technologies, announces that it has entered into a development and license agreement with Medtronic plc (“Medtronic”) (NYSE: MDT) to further the development of robotic assisted surgical technologies, as well as a separate license agreement with Medtronic in respect of certain intellectual property of Titan.

The development and license agreement provides for the development of robotic assisted surgical technologies for use by both Titan and Medtronic in their respective businesses. Titan will receive a series of payments totaling up to U.S. $31 million for Medtronic’s license to such technologies, as technology milestones are completed and verified. A steering committee comprised of representatives from Titan and Medtronic will be established to provide oversight regarding the work toward achievement of the milestones. One of the milestones of the agreement is for Titan to raise an additional U.S. $18 million of capital within four months of the development start date, which is expected to occur in June 2020.

To support development, Titan has received a senior secured loan of U.S. $1.5 million from Medtronic which …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “Titan Medical Announces Development and License Agreements With Medtronic and Senior Secured Loan”